Generics in Russia

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $350	36 Pages	MarketLine	December, 2024	MTLN19647867

Best Price Guarantee
Price	from $350
Length	36 Pages
Publisher	MarketLine
Published Date	December, 2024
SKU	MTLN19647867

Generics in Russia

Summary

Generics in Russia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
The Russian generics market recorded revenues of $15.4 billion in 2023, representing a compound annual growth rate (CAGR) of 15.1% between 2018 and 2023.
Market consumption volume increased with a CAGR of 3% between 2018 and 2023, to reach a total of 86.9% of total pharma volume in 2023.
According to GlobalData, in 2023, the Russian generics market grew by 2.3% annually. The growth is attributed to the country’s mounting aging population. According to the United States Census Bureau, in 2023, the population aged 65 years and above in Russia reached 24.7 million, up 2.8% over 2022.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Russia
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Russia
Leading company profiles reveal details of key generics market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Russia generics market with five year forecasts

Reasons to Buy

What was the size of the Russia generics market by value in 2023?
What will be the size of the Russia generics market in 2028?
What factors are affecting the strength of competition in the Russia generics market?
How has the market performed over the last five years?
What are the main segments that make up Russia's generics market?

1 Executive Summary: 1.1. Market value; 1.2. Market value forecast; 1.3. Market volume; 1.4. Market volume forecast; 1.5. Geography segmentation; 1.6. Market rivalry; 1.7. Competitive landscape
2 Market Overview: 2.1. Market definition; 2.2. Market analysis
3 Market Data: 3.1. Market value; 3.2. Market volume
4 Market Segmentation: 4.1. Geography segmentation
5 Market Outlook: 5.1. Market value forecast; 5.2. Market volume forecast
6 Five Forces Analysis: 6.1. Summary; 6.2. Buyer power; 6.3. Supplier power; 6.4. New entrants; 6.5. Threat of substitutes; 6.6. Degree of rivalry
7 Competitive Landscape: 7.1. Who are the leading players?; 7.2. What are the strengths of the leading player?; 7.3. Has the government recently implemented any initiatives aimed at boosting the market?
8 Company Profiles: 8.1. Biocad; 8.2. R-Pharm; 8.3. Pharmstandard; 8.4. Novartis AG
9 Macroeconomic Indicators: 9.1. Country data
10 Appendix: 10.1. Methodology; 10.2. Industry associations; 10.3. About MarketLine
List of Tables: Table 1: Russia generics market value: $ million, 2018-23; Table 2: Russia generics market volume: % of total pharma volume, 2018-23; Table 3: Russia generics market geography segmentation: $ million, 2023; Table 4: Russia generics market value forecast: $ million, 2023-28; Table 5: Russia generics market volume forecast: % of total pharma volume, 2023-28; Table 6: Biocad: Key Facts; Table 7: Biocad: Key Employees; Table 8: R-Pharm: Key Facts; Table 9: R-Pharm: Key Employees; Table 10: Pharmstandard: Key Facts; Table 11: Pharmstandard: Key Employees; Table 12: Novartis AG: Key Facts; Table 13: Novartis AG: Annual Financial Ratios; Table 14: Novartis AG: Key Employees; Table 15: Russia Size of Population (million), 2019-23; Table 16: Russia Real GDP (Constant 2010 Prices, $ Billion), 2019-23; Table 17: Russia GDP (Current Prices, $ Billion), 2019-23; Table 18: Russia Inflation, 2019-23; Table 19: Russia Consumer Price Index (Absolute), 2019-23; Table 20: Russia Exchange Rate, 2018-23
List of Figures: Figure 1: Russia generics market value: $ million, 2018-23; Figure 2: Russia generics market volume: % of total pharma volume, 2018-23; Figure 3: Russia generics market geography segmentation: % share, by value, 2023; Figure 4: Russia generics market value forecast: $ million, 2023-28; Figure 5: Russia generics market volume forecast: % of total pharma volume, 2023-28; Figure 6: Forces driving competition in the generics market in Russia, 2023; Figure 7: Drivers of buyer power in the generics market in Russia, 2023; Figure 8: Drivers of supplier power in the generics market in Russia, 2023; Figure 9: Factors influencing the likelihood of new entrants in the generics market in Russia, 2023; Figure 10: Factors influencing the threat of substitutes in the generics market in Russia, 2023; Figure 11: Drivers of degree of rivalry in the generics market in Russia, 2023